Drug repurposing for COVID-19: A review and a novel strategy to identify new targets and potential drug candidates

L Rodrigues, R Bento Cunha, T Vassilevskaia… - Molecules, 2022 - mdpi.com
In December 2019, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), the causative agent of coronavirus disease 2019 (COVID-19) was first identified in the …

Review on up-to-date status of candidate vaccines for COVID-19 disease

TM Belete - Infection and drug resistance, 2021 - Taylor & Francis
The global pandemic of COVID-19 caused by SARS-CoV-2 continues to spread and poses
serious threats to public health and economic stability throughout the world. Thus, to protect …

COVID‐19: An Overview of SARS‐CoV‐2 Variants—The Current Vaccines and Drug Development

N Bostanghadiri, P Ziaeefar, MG Mofrad… - BioMed Research …, 2023 - Wiley Online Library
The world is presently in crisis facing an outbreak of a health‐threatening microorganism
known as COVID‐19, responsible for causing uncommon viral pneumonia in humans. The …

Severe acute respiratory syndrome coronavirus 2 infection and blood safety

B He, Y Shi, B Li, X Duan, Q Wang - Acta Haematologica, 2022 - karger.com
Since the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it
has spread rapidly around the world and caused a serious global social crisis. During the …

How cooperative engagement programs strengthen sequencing capabilities for biosurveillance and outbreak response

AW Bartlow, EA Middlebrook, AT Romero… - Frontiers in Public …, 2021 - frontiersin.org
The threat of emerging and re-emerging infectious diseases continues to be a challenge to
public and global health security. Cooperative biological engagement programs act to build …

Drug repurposing for respiratory infections

J Israr, S Alam, A Kumar - Progress in molecular biology …, 2024 - pubmed.ncbi.nlm.nih.gov
Respiratory infections such as Coronavirus disease 2019 are a substantial worldwide health
challenge, frequently resulting in severe sickness and death, especially in susceptible …

[PDF][PDF] Reposicionamento de fármacos na pandemia de COVID-19: fundamentos e panorama de estudos clínicos

ES Vaz - 2022 - bdta.abcd.usp.br
UNIVERSIDADE DE SÃO PAULO Page 1 UNIVERSIDADE DE SÃO PAULO FACULDADE
DE CIÊNCIAS FARMACÊUTICAS Curso de Graduação em Farmácia-Bioquímica …

Reactogenicity of COVID-19 Vaccines; Insights from Cairo University Hospitals.

AM Sayed, MM Ahmed, S Fares, A Cordie… - Egyptian Journal of …, 2023 - journals.ekb.eg
Background: Since the emergence of the COVID-19 pandemic, most of the efforts were
directed towards developing new vaccines that are safe and effective to terminate the …

[PDF][PDF] Etude génomique de la variante omicron du SARS-CoV-2 au Maroc

B Sara - 2022 - toubkal.imist.ma
Résumé En 2020 le monde a été bouleversé par la survenue d'une pandémie liée à un
nouveau coronavirus: le SARS-CoV-2, de la maladie à Coronavirus 2019 (COVID-19), qui a …

Different Therapeutic Strategies to Tackle the Infection Associated with COVID-19

M Sharma, TU Singh, MC Lingaraju… - … to Combat COVID-19, 2021 - books.google.com
Covid-19 is a pandemic and the whole world is facing the loss in terms of morbidity and
mortality of the human resources. Therefore, there is an urgent need for various therapeutic …